Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Graefen

Showing results (671-680 of 850) with videos related to

Pageof 85
Sort By:
The Prostate|February 28, 2022
Survival after radical prostatectomy versus radiation therapy in clinical node-positive prostate cancerFrancesco Chierigo, Marco Borghesi, Christoph Würnschimmel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 24, 2009
Chromosome 8p deletions and 8q gains are associated with tumor progression and poor prognosis in prostate cancerAlexander T El Gammal, Michael Brüchmann, Jozef Zustin, et al.
Cancer Management and Research|December 5, 2018
Deletion of 3p13 is a late event linked to progression of <i>TMPRSS2</i>:<i>ERG</i> fusion prostate cancerMartina Kluth, Heinke Volta, Mohammad Hussein, et al.
World Journal of Urology|November 11, 2025
Robotic vs. open partial cytoreductive nephrectomy in metastatic renal cell carcinoma: adverse in-hospital outcomesQuynh Chi Le, Mattia Longoni, Andrea Marmiroli, et al.
Cancer Biology & Medicine|February 25, 2021
Reduced anoctamin 7 (ANO7) expression is a strong and independent predictor of poor prognosis in prostate cancerAndreas Marx, Lena Koopmann, Doris Höflmayer, et al.
Oncotarget|November 19, 2016
Deletion of 18q is a strong and independent prognostic feature in prostate cancerMartina Kluth, Maximilian Graunke, Christina Möller-Koop, et al.
BJU International|April 22, 2008
Comparison of stage migration patterns between Europe and the USA: an analysis of 11 350 men treated with radical prostatectomy for prostate cancerAndrea Gallina, Felix K-H Chun, Nazareno Suardi, et al.
European Urology|July 4, 2012
Systematic review and meta-analysis of studies reporting oncologic outcome after robot-assisted radical prostatectomyGiacomo Novara, Vincenzo Ficarra, Simone Mocellin, et al.
Experimental and Molecular Pathology|March 22, 2015
HDAC1 overexpression independently predicts biochemical recurrence and is associated with rapid tumor cell proliferation and genomic instability in prostate cancerChristoph Burdelski, Oliver M Ruge, Nathaniel Melling, et al.
Journal of Natural Products|November 22, 2022
Meroantarctines A-C, Meroterpenoids with Rearranged Skeletons from the Alga-Derived Fungus <i>Penicillium antarcticum</i> KMM 4685 with Potent p-Glycoprotein Inhibitory ActivityElena V Leshchenko, Alexandr S Antonov, Sergey A Dyshlovoy, et al.
Pageof 85

Showing results (671-680 of 850) with videos related to

Sort By:
Pageof 85
The Prostate|February 28, 2022
Survival after radical prostatectomy versus radiation therapy in clinical node-positive prostate cancerFrancesco Chierigo, Marco Borghesi, Christoph Würnschimmel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 24, 2009
Chromosome 8p deletions and 8q gains are associated with tumor progression and poor prognosis in prostate cancerAlexander T El Gammal, Michael Brüchmann, Jozef Zustin, et al.
Cancer Management and Research|December 5, 2018
Deletion of 3p13 is a late event linked to progression of <i>TMPRSS2</i>:<i>ERG</i> fusion prostate cancerMartina Kluth, Heinke Volta, Mohammad Hussein, et al.
World Journal of Urology|November 11, 2025
Robotic vs. open partial cytoreductive nephrectomy in metastatic renal cell carcinoma: adverse in-hospital outcomesQuynh Chi Le, Mattia Longoni, Andrea Marmiroli, et al.
Cancer Biology & Medicine|February 25, 2021
Reduced anoctamin 7 (ANO7) expression is a strong and independent predictor of poor prognosis in prostate cancerAndreas Marx, Lena Koopmann, Doris Höflmayer, et al.
Oncotarget|November 19, 2016
Deletion of 18q is a strong and independent prognostic feature in prostate cancerMartina Kluth, Maximilian Graunke, Christina Möller-Koop, et al.
BJU International|April 22, 2008
Comparison of stage migration patterns between Europe and the USA: an analysis of 11 350 men treated with radical prostatectomy for prostate cancerAndrea Gallina, Felix K-H Chun, Nazareno Suardi, et al.
European Urology|July 4, 2012
Systematic review and meta-analysis of studies reporting oncologic outcome after robot-assisted radical prostatectomyGiacomo Novara, Vincenzo Ficarra, Simone Mocellin, et al.
Experimental and Molecular Pathology|March 22, 2015
HDAC1 overexpression independently predicts biochemical recurrence and is associated with rapid tumor cell proliferation and genomic instability in prostate cancerChristoph Burdelski, Oliver M Ruge, Nathaniel Melling, et al.
Journal of Natural Products|November 22, 2022
Meroantarctines A-C, Meroterpenoids with Rearranged Skeletons from the Alga-Derived Fungus <i>Penicillium antarcticum</i> KMM 4685 with Potent p-Glycoprotein Inhibitory ActivityElena V Leshchenko, Alexandr S Antonov, Sergey A Dyshlovoy, et al.
Pageof 85